These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21275877)

  • 1. Evaluation of auricular lymph node cell lymphocyte proliferation and cytokine production as non-radioactive endpoints during murine contact allergy.
    Ulker OC; Atak A; Ates I; Karakaya A
    J Immunotoxicol; 2011 Jun; 8(2):131-9. PubMed ID: 21275877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior exposure to immunosuppressive organophosphorus or organochlorine compounds aggravates the T(H)1- and T(H)2-type allergy caused by topical sensitization to 2,4-dinitrochlorobenzene and trimellitic anhydride.
    Fukuyama T; Tajima Y; Ueda H; Hayashi K; Kosaka T
    J Immunotoxicol; 2011 Jun; 8(2):170-82. PubMed ID: 21534883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry.
    Jung KM; Jang WH; Lee YK; Yum YN; Sohn S; Kim BH; Chung JH; Park YH; Lim KM
    Toxicol Lett; 2012 Mar; 209(3):255-63. PubMed ID: 22245253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of the ex vivo LLNA: BrdU-ELISA to distinguish the sensitizers from irritants in respect of 3 end points-lymphocyte proliferation, ear swelling, and cytokine profiles.
    Arancioglu S; Ulker OC; Karakaya A
    Int J Toxicol; 2015; 34(1):24-30. PubMed ID: 25563296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4.
    Vandebriel RJ; De Jong WH; Spiekstra SW; Van Dijk M; Fluitman A; Garssen J; Van Loveren H
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):77-85. PubMed ID: 10637130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular expression of cytokines and granzyme B in auricular lymph nodes draining skin exposed to irritants and sensitizers.
    Ku HO; Jeong SH; Kang HG; Pyo HM; Cho JH; Son SW; Kim HR; Lee KJ; Ryu DY
    Toxicology; 2008 Sep; 250(2-3):116-23. PubMed ID: 18652873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure.
    De Jong WH; Arts JH; De Klerk A; Schijf MA; Ezendam J; Kuper CF; Van Loveren H
    Toxicology; 2009 Jul; 261(3):103-11. PubMed ID: 19422874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
    Piccotti JR; Kawabata TT
    J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a mouse model of chemical-induced asthma using trimellitic anhydride, a respiratory sensitizer, and dinitrochlorobenzene, a dermal sensitizer.
    Vanoirbeek JA; Tarkowski M; Vanhooren HM; De Vooght V; Nemery B; Hoet PH
    J Allergy Clin Immunol; 2006 May; 117(5):1090-7. PubMed ID: 16675337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contact allergic response to dinitrochlorobenzene (DNCB) in rats: insight from sensitization phase.
    Popov A; Mirkov I; Miljković D; Belij S; Zolotarevski L; Kataranovski D; Kataranovski M
    Immunobiology; 2011 Jul; 216(7):763-70. PubMed ID: 21281978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonradioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry.
    Lee JK; Park JH; Park SH; Kim HS; Oh HY
    J Pharmacol Toxicol Methods; 2002; 48(1):53-61. PubMed ID: 12750042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of allergenicity of some cosmetic mixtures by using ex vivo local lymph node assay-BrdU endpoints.
    Ulker OC; Kaymak Y; Karakaya A
    Int Arch Allergy Immunol; 2014; 164(4):301-7. PubMed ID: 25247696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative and quantitative evaluation of a local lymph node assay based on ex vivo interleukin-2 production.
    Azam P; Peiffer JL; Ourlin JC; Bonnet PA; Tissier MH; Vian L; Fabre I
    Toxicology; 2005 Jan; 206(2):285-98. PubMed ID: 15588920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-laboratory study to determine the reproducibility of LLNA:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Chen W; Xing C; Hou F
    J Pharmacol Toxicol Methods; 2016; 82():26-30. PubMed ID: 27456929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The local lymph node assay being too sensitive?
    Hans-Werner V; Jürgen AH
    Arch Toxicol; 2005 Dec; 79(12):721-8. PubMed ID: 16025312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of non-radioactive endpoints of ex vivo local lymph node assay-BrdU to investigate select contact sensitizers.
    Ulker OC; Ates I; Atak A; Karakaya A
    J Immunotoxicol; 2013; 10(1):1-8. PubMed ID: 22734851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiles in auricle skin as a possible additional endpoint for determination of sensitizers: A multi-endpoint evaluation of the local lymph node assay.
    Tsuchiyama H; Maeda A; Nakajima M; Kitsukawa M; Takahashi K; Miyoshi T; Mutsuga M; Asaoka Y; Miyamoto Y; Oshida K
    Toxicol Lett; 2017 Oct; 280():133-141. PubMed ID: 28826779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the local lymph node assay in assessment of immune function.
    van den Berg FA; Baken KA; Vermeulen JP; Gremmer ER; van Steeg H; van Loveren H
    Toxicology; 2005 Jul; 211(1-2):107-14. PubMed ID: 15863253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice.
    Tenda Y; Yamashita M; Kimura MY; Hasegawa A; Shimizu C; Kitajima M; Onodera A; Suzuki A; Seki N; Nakayama T
    J Allergy Clin Immunol; 2006 Sep; 118(3):725-33. PubMed ID: 16950294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.